Stereotactic Radiation Therapy for the Treatment of Glandular Metastases From Renal Cell Carcinoma
SABR for RCC metastases to the pancreas and adrenal gland is feasible, safe, and effective at achieving high rates of local control with a small risk of duodenal injury and adrenal insufficiency, respectively. Oncological outcomes of patients with SABR-treated mRCC with glandular metastasis were comparable to those without glandular metastasis.
Authors
- Allen Yen
- Raquibul Hannan (ORCID: https://orcid.org/0000-0003-1282-056X)
- Alana Christie (ORCID: https://orcid.org/0000-0002-7034-818X)
- Z. Wardak
- Todd A. Aguilera (ORCID: https://orcid.org/0000-0002-3734-3758)
- Mihailo Miljanic
- Kevin D. Courtney (ORCID: https://orcid.org/0000-0001-6273-3144)
- James Brugarolas (ORCID: https://orcid.org/0000-0002-8575-499X)
- Tidie Song
- Aurélie Garant (ORCID: https://orcid.org/0000-0003-3835-0906)
- Suzanne Cole (ORCID: https://orcid.org/0000-0001-8390-6315)
- Hans J. Hammers (ORCID: https://orcid.org/0000-0002-6224-4559)
- Young Suk Kwon
- Robert Timmerman
Institutions
- University of Texas Health Science Center at Dallas (US)
- Southwestern Medical Center (US)
- Parkwood Hospital (GB)
- Sidney Kimmel Comprehensive Cancer Center (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2025-06-13
- DOI
- https://doi.org/10.1016/j.adro.2025.101835
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Texas Southwestern Medical Center